1268521-85-2

Usage

Uses

Used in Pharmaceutical Industry:
Cyclobutanecarboxylic acid, 3-hydroxy-, transis used as an intermediate in the synthesis of pharmaceutical compounds for its unique structural properties and reactivity. It contributes to the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, Cyclobutanecarboxylic acid, 3-hydroxy-, transis employed as a building block for the creation of novel agrochemicals. Its specific chemical characteristics make it suitable for the development of pesticides and other agricultural chemicals.
Used in Material Science:
Cyclobutanecarboxylic acid, 3-hydroxy-, transis utilized in material science for the synthesis of advanced materials with unique properties. Its incorporation can lead to the development of new polymers, composites, and other materials with enhanced performance characteristics.

Upstream product

• 4934-99-0 methylester of 3-hydroxycyclobutane-1-carboxylic acid 
• 695-95-4 methyl 3-oxocyclobutanecarboxylate 
• 480449-99-8 3-hydroxycyclobutylcarboxylic acid benzyl ester 

Downstream Products

• 1089340-69-1 3-hydroxy-N-methylcyclobutanecarboxamide 

Relevant academic research and scientific papers

Method for synthesizing trans-3-hydroxy cyclobutyl formic acid

The invention belongs to the field of organic synthesis and discloses a method for synthesizing trans-3-hydroxy cyclobutyl formic acid. The method comprises the following steps: by using an appropriate reducing agent, reducing 3-carbonyl-cyclobutane formate (C1-C6 alkyl ester) into single trans-3-hydroxy cyclobutyl formic ether in an efficient stereoselectivity manner, and further performing a Mitsunobu reaction and hydrolysis, thereby obtaining single trans-3-hydroxy cyclobutyl formic acid. The method provided by the invention is high in synthesis method raw material availability, mild in reaction condition, good in stereoselectivity and relatively high in yield; in addition, aftertreatment and purification are both easy to operate, and the method is applicable to industrial amplified production.

Synthesis method of cis-3-hydroxycyclobutylcarboxylic acid

The invention belongs to the field of organic synthesis, and discloses a synthesis method of cis-3-hydroxycyclobutylcarboxylic acid. The synthesis method comprises the following steps: performing efficient stereoselective reduction on 3-carbonyl-cyclobutanecarboxylate (C1-C6 alkyl ester) into single cis-3-hydroxy-cyclobutanecarboxylate by using a proper reducing agent, and performing a hydrolysisreaction to finally obtain the single cis-3-hydroxy-cyclobutanecarboxylic acid. By the synthesis method, raw materials are easy to obtain, the reaction condition is mild, the stereoselectivity is good, and the yield is relatively high; in addition, post-treatment and purification are easy to operate, and the synthesis method is suitable for industrial scale-up production.

DIAMINE DERIVATIVES

A compound represented by formula (1):Q1-Q2-To-N(R1) -Q3-N(R2)-T1-Q4 [wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6- membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 represents the following group: (wherein Q5 is an alkylene group having 1 to 8 carbon atoms, or the like); and T0 and T1 are carbonyl groups or the like], a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after artificial valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.

Diamine derivatives

A compound represented by the general formula (1): Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4??(1) wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.

DIAMINE DERIVATIVES

A compound represented by the general formula (1):Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4 wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6- membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.